Oryzon to invest eur 20 million to develop new drugs
Catalan Economy
10 Sep 2009
Biotech company oryzon genomics has announced a four-year program to invest eur 20 million in the development of new drugs. oryzon ceo carlos buesa indicated that the company would use the resources to strengthen its research on biomarkers and antibody therapy.
oryzon recently opened its new 2,300-square-meter corporate headquarters in cornellà de llobregat (barcelona), with an investment of eur 2.5 million. the company expects revenue of eur 8 million for its current fiscal year.
source: expansión catalunya, 08/09/09
More News and Success Stories.
-
10 Jun 2026
See more MWC Barcelona generates €588 million for Catalonia’s economy and reinforces its global tech leadershipMWC Barcelona generates €588 million for Catalonia’s economy and reinforces its global tech leadership
-
10 Jun 2026
See more Port of Barcelona and Port of Shanghai sign strategic agreement to deepen cooperationPort of Barcelona and Port of Shanghai sign strategic agreement to deepen cooperation
-
05 Jun 2026
See more Barcelona-based Factorial reaches a €2.15 billion valuation after raising €129 millionBarcelona-based Factorial reaches a €2.15 billion valuation after raising €129 million
-
03 Jun 2026
See more Catalonia strengthens its European leadership in semiconductors through its active role in shaping the new European Chips ActCatalonia strengthens its European leadership in semiconductors through its active role in shaping the new European Chips Act
